Diagnosis and treatment of anti-insulin antibody-mediated labile glycaemia in insulin-treated diabetes.
David S ChurchPeter BarkerKeith A BurlingShah K ShinwariCarmel KennedyDiarmuid SmithDavid P MacfarlaneAndrew KernohanAnna StearsMuhammad A KaramatKaren WhyteParth NarendranDavid J HalsallRobert K SemplePublished in: Diabetic medicine : a journal of the British Diabetic Association (2023)
Anti-insulin antibodies should be considered in insulin-treated diabetes with unexplained glycaemic lability. Combining immunoassays with PEG precipitation can stratify their significance. Antibody depletion may be beneficial, but conservative measures often suffice.